Research on regulatory t-cells is being explored for its potential in developing immunotherapies. The focus of this research appears to be on various diseases, including graft-versus-host disease and cancer, with implications for immune-mediated diseases and therapeutic interventions. The studies seem to be investigating the mechanisms and potential applications of regulatory t-cells in immunotherapy, although the specific outcomes and diseases being targeted are not consistently defined.